Carmellose with glycerin and with hyaluronic acid – March 2023

Carmellose with glycerin and with hyaluronic acid: Eye drops containing carmellose sodium 5 mg with glycerin 9 mg and with hyaluronic acid 1 mg per mL, 10 mL; Optive Fusion® – March 2023 – May 2023 PBAC meetings

Brand names:
- Optive Fusion®
Pharmaceutical Company:
- Allergan Australia Pty Ltd
Condition/Indication: Severe dry eye syndrome
Meeting Date: March 2023
Public Summary Document (PSD) March 2023 May 2023 PBAC Meetings – (PDF 404KB)
Public Summary Document (PSD) March 2023 May 2023 PBAC Meetings – (Word 95KB)

Related Public Summary Documents

Carmellose with glycerin and with hyaluronic acid – May 2023

Last updated

25 August 2023